Futu news on August 1st: the main Hong Kong stock index was weak and volatile today. As of the press release, Hang Seng Index fell by 0.14%, national index fell by 0.16%, and Science and Technology Index fell by 0.94%.
In terms of sectors, network technology stocks fell today, with JD.com falling by more than 4%, JD Health, Ctrip Group, and Bilibili falling by more than 2%, and Baidu, NetEase, and Xiaomi falling by more than 1%.
Gold stocks rose, and Chi Silver GP and Lingbao Gold rose by more than 3%, and China Gold Intl rose by more than 2%.
Electric power stocks rose, and Power Assets rose by more than 3%, CGN Power and CKI Holdings rose by more than 2%, and China Longyuan rose by more than 1%.
Sporting goods stocks fell across the board, with Li Ning falling by more than 5%, Topsports falling by more than 3%, and Anta and Xtep falling by more than 1%.
Mainland real estate stocks fell across the board, with Yuexiu Property falling by more than 8%, Longfor Group and CIFI Hold GP falling by more than 3%, and Sunac and Shimao Group falling by more than 2%.
Contract research organizations stocks fell, with Viva Biotech falling by more than 3%, Wuxi Apptec falling by more than 2%, and Pharmaron falling by more than 1%.
In terms of individual stocks,$NEW ORIENTAL-S (09901.HK)$Net income in Q4 of fiscal year 2024 fell by 6.9% year-on-year to USD 26.972 million, down nearly 12%.
$EAST BUY (01797.HK)$Goldman Sachs fell by more than 4%, saying that the company's recent growth prospects have become unclear, and the low operating leverage may further pressure profit recovery.
$BUD APAC (01876.HK)$It fell by nearly 7% at one point and the current decline narrowed to about 1.5%. The holding shareholders of Bud APAC had a net income of USD 0.541 billion, down 5.91% year-on-year in the first half of the year.
$SIRNAOMICS-B (02257.HK)$It rose by more than 7%, signing a patent transfer and license agreement with Sagesse Bio.
Editor/Jeffy